2usn: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 4: Line 4:
|PDB= 2usn |SIZE=350|CAPTION= <scene name='initialview01'>2usn</scene>, resolution 2.2&Aring;
|PDB= 2usn |SIZE=350|CAPTION= <scene name='initialview01'>2usn</scene>, resolution 2.2&Aring;
|SITE= <scene name='pdbsite=INH:Site+Inh+Is+The+Binding+Site+For+The+Amide-Thiadiazole+I+...'>INH</scene>, <scene name='pdbsite=ZN1:Zn1+Are+The+Ligands+Of+Catalytic+(Zn+257)+Zn+Ion'>ZN1</scene> and <scene name='pdbsite=ZN2:Zn2+Are+The+Ligands+Of+Structural+(Zn+258)+Zn+Ion'>ZN2</scene>
|SITE= <scene name='pdbsite=INH:Site+Inh+Is+The+Binding+Site+For+The+Amide-Thiadiazole+I+...'>INH</scene>, <scene name='pdbsite=ZN1:Zn1+Are+The+Ligands+Of+Catalytic+(Zn+257)+Zn+Ion'>ZN1</scene> and <scene name='pdbsite=ZN2:Zn2+Are+The+Ligands+Of+Structural+(Zn+258)+Zn+Ion'>ZN2</scene>
|LIGAND= <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene> and <scene name='pdbligand=IN8:[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER'>IN8</scene>
|LIGAND= <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=IN8:[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC+ACID+BENZYL+ESTER'>IN8</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene>
|ACTIVITY= [http://en.wikipedia.org/wiki/Stromelysin_1 Stromelysin 1], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.17 3.4.24.17]  
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Stromelysin_1 Stromelysin 1], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.17 3.4.24.17] </span>
|GENE=  
|GENE=  
|DOMAIN=
|RELATEDENTRY=
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2usn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2usn OCA], [http://www.ebi.ac.uk/pdbsum/2usn PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2usn RCSB]</span>
}}
}}


Line 14: Line 17:
==Overview==
==Overview==
The binding of two 5-substituted-1,3,4-thiadiazole-2-thione inhibitors to the matrix metalloproteinase stromelysin (MMP-3) have been characterized by protein crystallography. Both inhibitors coordinate to the catalytic zinc cation via an exocyclic sulfur and lay in an unusual position across the unprimed (P1-P3) side of the proteinase active site. Nitrogen atoms in the thiadiazole moiety make specific hydrogen bond interactions with enzyme structural elements that are conserved across all enzymes in the matrix metalloproteinase class. Strong hydrophobic interactions between the inhibitors and the side chain of tyrosine-155 appear to be responsible for the very high selectivity of these inhibitors for stromelysin. In these enzyme/inhibitor complexes, the S1' enzyme subsite is unoccupied. A conformational rearrangement of the catalytic domain occurs that reveals an inherent flexibility of the substrate binding region leading to speculation about a possible mechanism for modulation of stromelysin activity and selectivity.
The binding of two 5-substituted-1,3,4-thiadiazole-2-thione inhibitors to the matrix metalloproteinase stromelysin (MMP-3) have been characterized by protein crystallography. Both inhibitors coordinate to the catalytic zinc cation via an exocyclic sulfur and lay in an unusual position across the unprimed (P1-P3) side of the proteinase active site. Nitrogen atoms in the thiadiazole moiety make specific hydrogen bond interactions with enzyme structural elements that are conserved across all enzymes in the matrix metalloproteinase class. Strong hydrophobic interactions between the inhibitors and the side chain of tyrosine-155 appear to be responsible for the very high selectivity of these inhibitors for stromelysin. In these enzyme/inhibitor complexes, the S1' enzyme subsite is unoccupied. A conformational rearrangement of the catalytic domain occurs that reveals an inherent flexibility of the substrate binding region leading to speculation about a possible mechanism for modulation of stromelysin activity and selectivity.
==Disease==
Known diseases associated with this structure: Coronary heart disease, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=185250 185250]]


==About this Structure==
==About this Structure==
Line 29: Line 29:
[[Category: Finzel, B C.]]
[[Category: Finzel, B C.]]
[[Category: Junior, G L.Bryant.]]
[[Category: Junior, G L.Bryant.]]
[[Category: CA]]
[[Category: IN8]]
[[Category: ZN]]
[[Category: collagen degradation]]
[[Category: collagen degradation]]
[[Category: fibroblast]]
[[Category: fibroblast]]
Line 37: Line 34:
[[Category: metalloprotease]]
[[Category: metalloprotease]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 18:39:49 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 05:04:26 2008''